Strategic Platform Hurdle offers an API-first, end-to-end diagnostic platform enabling rapid go-live for digital health companies, clinics, and pharma brands. This presents an opportunity to upsell bespoke integrations, branded testing workflows, and scalable lab analysis services to potential customers seeking faster time-to-value.

Saliva Biomarkers Recent launch of saliva-based DNA methylation biomarker targeting systemic chronic inflammation opens a pathway to partner for aging, longevity, and wellness studies. Sales conversations can target research collaboratives, CROs, and biotechs exploring non-invasive biomarker panels.

Phlebotomy & Portal New Partner Phlebotomy Booking Module and redesigned Partner Portal reduce friction for onboarding and site integration. This creates opportunities to bundle field services, logistics, and marketplace-like partner ecosystems for faster deployment and expanded reach.

Flexible Ordering Flexible Biomarker Ordering addresses friction in diagnostics, signaling a market niche for streamlined test catalog management and adaptable procurement. Engage with healthcare networks and digital health platforms needing configurable testing workflows.

Clinical & Home Testing Past launches of at-home HbA1c and vitamin D home-testing products indicate demand for consumer-enabled diagnostics. Target payer programs, employer health initiatives, and consumer health brands seeking scalable at-home testing capabilities and data partnership opportunities.